Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange

Matthew R. Sullivan, Alexey V. Danilov, Frederick Lansigan, Nancy M. Dunbar

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma.

Original languageEnglish (US)
Pages (from-to)308-310
Number of pages3
JournalJournal of Clinical Apheresis
Volume30
Issue number5
DOIs
StatePublished - Oct 2015

Keywords

  • carfilzomib
  • multiple myeloma
  • plasma exchange
  • thrombotic microangiopathy

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange'. Together they form a unique fingerprint.

  • Cite this